TSM
238.73
+1.49%↑
ORCL
252.68
+3.37%↑
ASML.US
698.92
+1.2%↑
IBM
251.84
+0.88%↑
NOW
923.21
+1.04%↑
TSM
238.73
+1.49%↑
ORCL
252.68
+3.37%↑
ASML.US
698.92
+1.2%↑
IBM
251.84
+0.88%↑
NOW
923.21
+1.04%↑
TSM
238.73
+1.49%↑
ORCL
252.68
+3.37%↑
ASML.US
698.92
+1.2%↑
IBM
251.84
+0.88%↑
NOW
923.21
+1.04%↑
TSM
238.73
+1.49%↑
ORCL
252.68
+3.37%↑
ASML.US
698.92
+1.2%↑
IBM
251.84
+0.88%↑
NOW
923.21
+1.04%↑
TSM
238.73
+1.49%↑
ORCL
252.68
+3.37%↑
ASML.US
698.92
+1.2%↑
IBM
251.84
+0.88%↑
NOW
923.21
+1.04%↑
24h
Current
Min
79.51
Max
82.73
Income | -7.8M 31M |
---|---|
Sales | -31M 611M |
P/E Sector Avg | 27.604 71.636 |
EPS | 1.5 |
Profit margin | 5.013 |
Employees | 31,102 |
EBITDA | -40M 49M |
Recommendations | Buy |
---|---|
12 Months Forecast | +48.97% upside |
Next Earnings | 14 Aug 2025 |
---|
Market Cap | -2B 4.1B |
---|---|
Previous open | 78.93 |
Previous close | 81.76 |
By Acuity
24%
76%
52 / 407 Technology
By Trading Central
Confidence
Bullish Evidence
117.37 / N/A Support & Resistance
Past performance is not a reliable indicator of future results.
4 Aug 2025, 21:42 UTC
Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone
DJ
Read
4 Aug 2025, 21:21 UTC
Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update
DJ
Read
4 Aug 2025, 20:45 UTC
Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb
DJ
Read
4 Aug 2025, 19:15 UTC
TransMedics Group Shares Rise on FDA Approval for Clinical Trial
DJ
Read
4 Aug 2025, 23:41 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Read
4 Aug 2025, 23:41 UTC
Nikkei May Rise on Fed Stimulus Hopes
DJ
Read
4 Aug 2025, 23:28 UTC
Global Equities Roundup: Market Talk
DJ
Read
4 Aug 2025, 23:28 UTC
Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk
DJ
Read
4 Aug 2025, 21:30 UTC
Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com
DJ
Read
4 Aug 2025, 21:21 UTC
Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com
DJ
Read
4 Aug 2025, 21:18 UTC
Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com
DJ
Read
4 Aug 2025, 20:25 UTC
India Hits Back Over Russian Oil Purchases -- Market Talk
DJ
Read
4 Aug 2025, 20:25 UTC
Transocean 2Q Loss $938M >RIG
DJ
Read
4 Aug 2025, 20:25 UTC
Transocean 2Q Loss/Shr $1.06 >RIG
DJ
Read
4 Aug 2025, 20:18 UTC
Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com
DJ
Read
4 Aug 2025, 20:15 UTC
Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX
DJ
Read
4 Aug 2025, 20:14 UTC
Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX
DJ
Read
4 Aug 2025, 20:14 UTC
Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX
DJ
Read
4 Aug 2025, 20:14 UTC
Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX
DJ
Read
4 Aug 2025, 20:13 UTC
Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX
DJ
Read
4 Aug 2025, 20:09 UTC
Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM
DJ
Read
4 Aug 2025, 20:06 UTC
Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com
DJ
Read
4 Aug 2025, 20:01 UTC
Vertex Pharmaceuticals 2Q Net $1.03B >VRTX
DJ
Read
4 Aug 2025, 20:01 UTC
Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX
DJ
Read
4 Aug 2025, 20:01 UTC
Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX
DJ
Read
4 Aug 2025, 20:01 UTC
Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX
DJ
Read
4 Aug 2025, 19:41 UTC
U.S. Natural Gas Futures Settle Lower -- Market Talk
DJ
Read
4 Aug 2025, 19:28 UTC
U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk
DJ
Read
4 Aug 2025, 19:07 UTC
Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk
DJ
Read
4 Aug 2025, 18:27 UTC
Gold Climbs on Rate Cut Speculation -- Market Talk
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 118.86 USD 48.97%
High 153 USD
Low 87 USD
Based on 15 Wall Street analysts offering 12 month price targets forGlobant SA - Dist in the last 3 months.
By TipRanks
Buy
15 ratings
9
Buy
6
Hold
0
Sell
Based on 15 analysts giving stock ratings to Globant SA - Dist in the past 3 months.
By Trading Central
Short Term
Bullish Evidence
Recent bullish events outweigh bearish events.
Intermediate Term
Bullish Evidence
Recent bullish events outweigh bearish events.
Long Term
Bearish Evidence
All events are bearish.
By Acuity
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$